Anna Takácsi-Nagy

Dr. Anna Takácsi-Nagy

PannonPharma (Hungary), Budakalász, Pest, Hungary

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2022 in Plants
Verified
Journal Article
Open access
PDF file
NPNora Papp
Nora Papp
DPDragica Purger
Dragica Purger
SCSzilvia Czigle
Szilvia Czigle
DCDóra Czégényi
Dóra Czégényi
SSSzilvia Stranczinger
Szilvia Stranczinger
RFRita Filep
Rita Filep
The geographical and ecological features of Transylvania enable the wide ethnobotanical use of pine species. The aim of this study was to survey the current ethnomedicinal and other traditional use of pine species of Hungarian-speaking ethnic groups in Transylvania and to compare them with earlier reports performed in Transylvania and from other countries related to the Carpathian Basin. Information on pine species was obtained using semi-structured interviews with 515 Transylvanian informants from 18 villages in the period 2007–2019. The young shoots of Abies alba Mill., Picea abies (L.) H. Karst., Pinus nigra J. F. Arnold, and Pinus sylvestris L. were applied to treat respiratory diseases, while the resin was used for dental problems. Syrup and decoction were made from the cones of all species, except Abies alba. Picea abies was the most frequently documented with seven preparations from different parts (even needles), and this species was mentioned in the treatment of 21 diseases. The least recorded was Abies alba, which was applied for coughs and decayed teeth. We recorded the use of the cones and needles of Picea abies for dyspnoea, thyroid glands, and kidney disorders, previously unknown in ethnomedicinal literature. Our data on the pine species confirm their current use and significance in Transylvania.

19 February 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ASAla' Salem
Ala' Salem
ATAnna Takácsi-Nagy
Anna Takácsi-Nagy
SNSándor Nagy
Sándor Nagy
AHAlexandra Hagymási
Alexandra Hagymási
FGFruzsina Gősi
Fruzsina Gősi
ASAleksandar Széchenyi
Aleksandar Széchenyi
Drug–drug cocrystals are formulated to produce combined medication, not just to modulate active pharmaceutical ingredient (API) properties. Nano-crystals adjust the pharmacokinetic properties and enhance the dissolution of APIs. Nano-cocrystals seem to enhance API properties by combining the benefits of both technologies. Despite the promising opportunities of nano-sized cocrystals, the research at the interface of nano-technology and cocrystals has, however, been described to be in its infancy. In this study, high-pressure homogenization (HPH) and high-power ultrasound were used to prepare nano-sized cocrystals of 4-aminosalysilic acid and sulfamethazine in order to establish differences between the two methods in terms of cocrystal size, morphology, polymorphic form, and dissolution rate enhancement. It was found that both methods resulted in the formation of form I cocrystals with a high degree of crystallinity. HPH yielded nano-sized cocrystals, while those prepared by high-power ultrasound were in the micro-size range. Furthermore, HPH produced smaller-size cocrystals with a narrow size distribution when a higher pressure was used. Cocrystals appeared to be needle-like when prepared by HPH compared to those prepared by high-power ultrasound, which had a different morphology. The highest dissolution enhancement was observed in cocrystals prepared by HPH; however, both micro- and nano-sized cocrystals enhanced the dissolution of sulfamethazine.

1 March 2012 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
ATAnna Takácsi-Nagy
Anna Takácsi-Nagy
FKFerenc Kilár
Ferenc Kilár
CPCsilla Páger
Csilla Páger
RMRichard A. Mosher
Richard A. Mosher
WTWolfgang Thormann
Wolfgang Thormann

4 September 2012 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
CPCsilla Páger
Csilla Páger
AVAndrea Vargová
Andrea Vargová
ATAnna Takácsi-Nagy
Anna Takácsi-Nagy
ÁDÁgnes Dörnyei
Ágnes Dörnyei
FKFerenc Kilár
Ferenc Kilár

4 October 2016 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
ATAnna Takácsi-Nagy
Anna Takácsi-Nagy
FKFerenc Kilár
Ferenc Kilár
WTWolfgang Thormann
Wolfgang Thormann

10 January 2021 in Orvosi Hetilap
Verified
Journal Article
Open access
PDF file
BKBalázs Kovács
Balázs Kovács
BLBoglárka Láng
Boglárka Láng
ATAnna Takácsi-Nagy
Anna Takácsi-Nagy
GHGyörgyi Horváth
Györgyi Horváth
CCCecília Czakó
Cecília Czakó
IKIllés Kovács
Illés Kovács
Összefoglaló. A szárazszem-panaszok hátterében gyakran áll Meibom-mirigy-diszfunkció, melynek felismerése kiemelten fontos a hatékony kezelés érdekében. A Meibom-mirigyek kóros működése miatt a termelt lipid nem oszlik el megfelelően a szemfelszínen, így a könnyfilm párolgása fokozódik. A könnytermelési zavar következtében szárazszem-panaszok alakulnak ki, melyek a hagyományos könnypótló kezelésre rendszerint csak átmenetileg javulnak. A Meibom-mirigy-diszfunkciót gyakran kíséri a szemhéjszél Demodex-atka-fertőzése – az atka eradikálása szükséges a mirigyek működésének helyreállításához és ezáltal a panaszok megszüntetéséhez. A Meibom-mirigy-diszfunkció a leggyakrabban enyhe formában jelentkezik; a terápia ilyenkor a beteg által is elvégezhető szemhéjtisztításból áll, míg a gyógyszeres kezelés csak az előrehaladottabb, kifejezett gyulladással járó formákban szükséges. Az összefoglaló áttekinti a Meibom-mirigy-diszfunkció klinikai jeleivel és kezelésével kapcsolatos legfontosabb tudnivalókat, különös tekintettel a Demodex-fertőzés felismerésére és kezelésére vonatkozóan. Orv Hetil. 2021; 162(2): 43–51. Summary. The onset of dry eye complaints is often a result of Meibomian gland dysfunction and its diagnosis is essential for effective treatment. In the case of Meibomian gland dysfunction, there is an increased evaporation of the tear film due to the abnormal secretion of lipids that cannot spread on the ocular surface. The treatment of dry eye complaints associated with Meibomian gland dysfunction with tear supplementation is usually ineffective and only results in an intermittent relief of complaints. Meibomian gland dysfunction is often associated with Demodex infestation of the eyelids, and eradicating the mites is essential to re-establish normal meibum production and thus, decreasing ocular complaints. In most cases, Meibomian gland dysfunction is mild, and the treatment of these forms is based on ocular hygiene performed by the patient, while only more advanced forms with inflammatory processes require pharmacologic treatment. This review summarizes the most important knowledge on the clinical signs and treatment of Meibomian gland dysfunction with particular attention to the diagnosis and treatment of ocular Demodex infection. Orv Hetil. 2021; 162(2): 43–51.